PATH-18. SUBCLASSIFICATION OF LOW-GRADE GLIOMAS CONSIDERING TERT PROMOTER MUTATION AND ATRX LOSS: BEYOND THE 2016 WHO CLASSIFICATION

BACKGROUND: Grade II glioma is a heterogeneous group of various pathologies. 2016 WHO classification defined subgroups of Grade II gliomas based on isocitrate dehydrogenase (IDH) mutation and 1p/19q codeletion status. However, implications of telomerase reverse transcriptase promoter (TERTp) mutatio...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Neuro Oncol
Huvudupphovsmän: Hee Chang, Jong, Hoon Roh, Tae, Hyung Moon, Ju, Hyun Kim, Eui, Kang, Seok-Gu, Hoon Kim, Se, Suh, Chang-Ok
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2018
Ämnen:
Abstracts
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216526/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.674
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk